PMSNF (Proteome Sciences) Forward PE Ratio: 0.00 (As of Jul. 04, 2026)


What is Proteome Sciences Forward PE Ratio?

Proteome Sciences PMSNF Forward PE Ratio is 0.00 as of Jul. 04, 2026. The stock has 6 warning signs investors should review. Among 87 Medical Diagnostics & Research companies, Proteome Sciences ranks worse than 1149424.14% on this metric.

Proteome Sciences's Forward PE Ratio for today is 0.00.

Proteome Sciences's PE Ratio without NRI for today is 0.00.

Proteome Sciences's PE Ratio (TTM) for today is 0.00.

Proteome Sciences  (OTCPK:PMSNF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Proteome Sciences Forward PE Ratio Related Terms

Proteome Sciences Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Proteome Sciences's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteome Sciences Forward PE Ratio Chart

Proteome Sciences Annual Data
Trend
Forward PE Ratio

Proteome Sciences Semi-Annual Data
Forward PE Ratio

PMSNF vs TMO, DHR, IDXX: Forward PE Ratio Comparison

For the Diagnostics & Research subindustry, Proteome Sciences's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proteome Sciences Forward PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Proteome Sciences's Forward PE Ratio falls into.


Proteome Sciences Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Proteome Sciences (PMSNF) has a Forward PE Ratio of 0.00 as of Jul. 04, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Proteome Sciences and its competitors. According to the industry distribution chart, Proteome Sciences ranks #999999 out of 87 companies in the Medical Diagnostics & Research industry.
Is Proteome Sciences' Forward PE Ratio too high?
Proteome Sciences' current Forward PE Ratio is 0.00. Based on the distribution chart, Proteome Sciences ranks #999999 out of 87 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Proteome Sciences' Forward PE Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Proteome Sciences ranks #999999 out of 87 companies for Forward PE Ratio. This places Proteome Sciences in the lower half of its industry. The industry median Forward PE Ratio is 21.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Diagnostics & Research company?
The median Forward PE Ratio among Medical Diagnostics & Research companies is 21.57, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Proteome Sciences and its competitors. For the Medical Diagnostics & Research industry, the median Forward PE Ratio is 21.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proteome Sciences's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Proteome Sciences (PMSNF) has a current Forward PE Ratio of 0.00. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 17.5% below its estimated fair value. The current Forward PE Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Proteome Sciences (PMSNF), the current Forward PE Ratio is 0.00 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proteome Sciences Business Description

Other Exchanges PRMl:UKPRM:UKPI2:Germany
Address Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.